{"id": "1347279340589862912", "creation": 1610051400.0, "user_id": "18026170", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 1, "quote_count": 0}}, "text": ".@BayerPharma lends weight to @CureVacRNA\u2019s #CVnCoV #mRNA-based #vaccine vs #SARSCoV2 #infection\n\nTo support #CureVac within EU &amp; holds option to become Marketing Authorization Holder outside EU\n\nhttps://t.co/cMkFA3AV6v\n#COVID19 #InfectiousDiseases https://t.co/PSuApORICG", "first_save": 1634559108.199414, "hashtags": ["#CVNCOV", "#MRNA", "#VACCINE", "#SARSCOV2", "#INFECTION", "#CUREVAC", "#COVID19", "#INFECTIOUSDISEASES"]}